In this double-blind study, the efficacy and safety of a single intravenous dose of a novel antiemetic, granisetron, was assessed at two dose levels (40 ~g/kg and 160 Ixg/kg). A group of 355 patients were given prophylactic granisetron prior to receiving highdose cisplatin chemotherapy. In the first
A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin
โ Scribed by Tonato, M.; Roila, F.; Del Favero, A.; Tognoni, G.; Franzosi, M.G.; Pampallona, S.
- Book ID
- 122299517
- Publisher
- Elsevier Science
- Year
- 1985
- Weight
- 388 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The field of high-dose chemotherapy with stem cell transplantation has been expanded recently as a treatment for solid tumors and hematological malignancies. Severe emesis remains one of the main extramedullary side-effects of high-dose regimens during the first week of treatment. Traditional antiem
Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high